Detalhe da pesquisa
1.
[18 F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma.
Hematol Oncol
; 41(4): 674-682, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209024
2.
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning.
Eur J Nucl Med Mol Imaging
; 45(13): 2426-2441, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785514
3.
Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.
Eur J Nucl Med Mol Imaging
; 44(11): 1915-1927, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681192
4.
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis.
Endocrine
; 84(2): 704-710, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324106
5.
A PET-Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers.
Adv Sci (Weinh)
; : e2308255, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757578
6.
First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor.
Biomedicines
; 11(2)2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831181
7.
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.
Semin Nucl Med
; 52(2): 191-214, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996594
8.
Clinical application of spectral electromagnetic interaction in breast cancer: diagnostic results of a pilot study.
Tumori
; 92(3): 207-12, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16869237